<?xml version='1.0' encoding='utf-8'?>
<document id="26075835"><sentence text="In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs."><entity charOffset="47-57" id="DDI-PubMed.26075835.s1.e0" text="carbapenem" /><entity charOffset="117-130" id="DDI-PubMed.26075835.s1.e1" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.26075835.s1.e0" e2="DDI-PubMed.26075835.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s1.e0" e2="DDI-PubMed.26075835.s1.e1" /></sentence><sentence text="1" /><sentence text=" Our previous in vitro studies suggest that inhibition of the acylpeptide hydrolase (APEH) activity as valproic acid glucuronide (VPA-G) hydrolase by carbapenems in human liver cytosol is a key process for clinical drug-drug interaction (DDI) of valproic acid (VPA) with carbapenems"><entity charOffset="103-128" id="DDI-PubMed.26075835.s3.e0" text="valproic acid glucuronide" /><entity charOffset="130-135" id="DDI-PubMed.26075835.s3.e1" text="VPA-G" /><entity charOffset="150-161" id="DDI-PubMed.26075835.s3.e2" text="carbapenems" /><entity charOffset="246-259" id="DDI-PubMed.26075835.s3.e3" text="valproic acid" /><entity charOffset="261-264" id="DDI-PubMed.26075835.s3.e4" text="VPA" /><entity charOffset="271-282" id="DDI-PubMed.26075835.s3.e5" text="carbapenems" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e0" e2="DDI-PubMed.26075835.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e0" e2="DDI-PubMed.26075835.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e0" e2="DDI-PubMed.26075835.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e0" e2="DDI-PubMed.26075835.s3.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e0" e2="DDI-PubMed.26075835.s3.e4" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e0" e2="DDI-PubMed.26075835.s3.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e1" e2="DDI-PubMed.26075835.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e1" e2="DDI-PubMed.26075835.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e1" e2="DDI-PubMed.26075835.s3.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e1" e2="DDI-PubMed.26075835.s3.e4" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e1" e2="DDI-PubMed.26075835.s3.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e2" e2="DDI-PubMed.26075835.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e2" e2="DDI-PubMed.26075835.s3.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e2" e2="DDI-PubMed.26075835.s3.e4" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e2" e2="DDI-PubMed.26075835.s3.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e3" e2="DDI-PubMed.26075835.s3.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e3" e2="DDI-PubMed.26075835.s3.e4" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e3" e2="DDI-PubMed.26075835.s3.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e4" e2="DDI-PubMed.26075835.s3.e4" /><pair ddi="false" e1="DDI-PubMed.26075835.s3.e4" e2="DDI-PubMed.26075835.s3.e5" /></sentence><sentence text=" Here, we investigated whether in vivo DDI of VPA with meropenem (MEPM) was caused via inhibition of APEH in dogs"><entity charOffset="55-64" id="DDI-PubMed.26075835.s4.e0" text="meropenem" /><entity charOffset="66-70" id="DDI-PubMed.26075835.s4.e1" text="MEPM" /><entity charOffset="46-49" id="DDI-PubMed.26075835.s4.e2" text="VPA" /><pair ddi="false" e1="DDI-PubMed.26075835.s4.e2" e2="DDI-PubMed.26075835.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s4.e2" e2="DDI-PubMed.26075835.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s4.e2" e2="DDI-PubMed.26075835.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s4.e0" e2="DDI-PubMed.26075835.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s4.e0" e2="DDI-PubMed.26075835.s4.e1" /></sentence><sentence text=" 2" /><sentence text=" More rapid decrease of plasma VPA levels and increased urinary excretion of VPA-G were observed after co-administration with MEPM compared with those after without co-administration, whereas the plasma level and bile excretion of VPA-G showed no change"><entity charOffset="77-79" id="DDI-PubMed.26075835.s6.e0" text="VPA-G" /><entity charOffset="231-233" id="DDI-PubMed.26075835.s6.e1" text="VPA-G" /><entity charOffset="31-33" id="DDI-PubMed.26075835.s6.e2" text="VPA" /><entity charOffset="126-128" id="DDI-PubMed.26075835.s6.e3" text="MEPM" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e2" e2="DDI-PubMed.26075835.s6.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e2" e2="DDI-PubMed.26075835.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e2" e2="DDI-PubMed.26075835.s6.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e2" e2="DDI-PubMed.26075835.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e0" e2="DDI-PubMed.26075835.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e0" e2="DDI-PubMed.26075835.s6.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e0" e2="DDI-PubMed.26075835.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e3" e2="DDI-PubMed.26075835.s6.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s6.e3" e2="DDI-PubMed.26075835.s6.e1" /></sentence><sentence text=" 3" /><sentence text=" Dog VPA-G hydrolase activity, inhibited by carbapenems, was mainly located in cytosol from both the liver and kidney"><entity charOffset="5-8" id="DDI-PubMed.26075835.s8.e0" text="VPA-G" /></sentence><sentence text=" APEH-immunodepleted cytosols lacked VPA-G hydrolase activity"><entity charOffset="37-41" id="DDI-PubMed.26075835.s9.e0" text="VPA-G" /></sentence><sentence text=" Hepatic and renal APEH activity was negligible even at 24 h after dosing of MEPM to a dog"><entity charOffset="77-81" id="DDI-PubMed.26075835.s10.e0" text="MEPM" /></sentence><sentence text=" 4" /><sentence text=" In conclusion, DDI of VPA with carbapenems in dogs is caused by long-lasting inhibition of APEH-mediated VPA-G hydrolysis by carbapenems, which could explain the delayed recovery of plasma VPA levels to the therapeutic window even after discontinuation of carbapenems in humans"><entity charOffset="32-43" id="DDI-PubMed.26075835.s12.e0" text="carbapenems" /><entity charOffset="126-137" id="DDI-PubMed.26075835.s12.e1" text="carbapenems" /><entity charOffset="257-268" id="DDI-PubMed.26075835.s12.e2" text="carbapenems" /><entity charOffset="106-116" id="DDI-PubMed.26075835.s12.e3" text="VPA-G" /><entity charOffset="23-33" id="DDI-PubMed.26075835.s12.e4" text="VPA" /><entity charOffset="190-200" id="DDI-PubMed.26075835.s12.e5" text="VPA" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e4" e2="DDI-PubMed.26075835.s12.e4" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e4" e2="DDI-PubMed.26075835.s12.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e4" e2="DDI-PubMed.26075835.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e4" e2="DDI-PubMed.26075835.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e4" e2="DDI-PubMed.26075835.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e4" e2="DDI-PubMed.26075835.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e0" e2="DDI-PubMed.26075835.s12.e0" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e0" e2="DDI-PubMed.26075835.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e0" e2="DDI-PubMed.26075835.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e0" e2="DDI-PubMed.26075835.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e0" e2="DDI-PubMed.26075835.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e3" e2="DDI-PubMed.26075835.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e3" e2="DDI-PubMed.26075835.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e3" e2="DDI-PubMed.26075835.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e3" e2="DDI-PubMed.26075835.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e1" e2="DDI-PubMed.26075835.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e1" e2="DDI-PubMed.26075835.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e1" e2="DDI-PubMed.26075835.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e5" e2="DDI-PubMed.26075835.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26075835.s12.e5" e2="DDI-PubMed.26075835.s12.e2" /></sentence><sentence text=" " /></document>